<DOC>
	<DOCNO>NCT02982863</DOCNO>
	<brief_summary>1 . To understand treatment pattern OACs baseline patient characteristic Japanese Non-Valvular Atrial Fibrillation ( NVAF ) patient 2 . To determine whether warfarin dabigatran new user group balance use propensity score match use pre-specified baseline covariates . 3 . As exploratory analysis , assess mean duration on-therapy follow-up time database</brief_summary>
	<brief_title>Treatment Pattern Oral Anticoagulants ( OAC ) Japan</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Inclusion criterion : Patients age &gt; 18 yearold confirm diagnosis NVAF ( ICD 10 code I48 ) , new starter either dabigatran , warfarin , apixaban edoxaban , prescription OACs for12 month prior index date ( define first prescription OACs ( period define baseline period ) ) , index date 14 Mar 2011 30 June 2016 Exclusion criterion : Patients le 12 month enrolment prior index date , dialysis kidney transplant recipient baseline period , either atrial flutter , valvular AF , mechanical valve placement , rheumatic AF , and/or mitral valve prolapse/regurge/stenosis baseline period , record deep vein thrombosis pulmonary embolism &lt; 6 month Atrial Fibrillation ( AF ) diagnosis baseline period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>